Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Pre-Tax Margin Over TimeContracting
Percentile Rank31
3Y CAGR-32.9%
5Y CAGR-25.2%
Studio
Year-over-Year Change

Pre-tax income as a percentage of revenue

3Y CAGR
-32.9%/yr
vs -5.8%/yr prior
5Y CAGR
-25.2%/yr
Recent deceleration
Acceleration
-27.1pp
Decelerating
Percentile
P31
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
6 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM8.73%-63.5%
202423.92%-7.4%
202325.82%-10.7%
202228.91%-15.4%
202134.16%-8.2%
202037.19%-2.3%
201938.07%+3.8%
201836.68%+10.6%
201733.17%+231.4%
201610.01%-